Drugs / Abcertin
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT04787887 Comparator | Jan → Sep 2020 | Gaucher disease | ISU Abxis Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Abcertin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04787887 ↗ |
| Route | Intravenous | “Single Intravenous Administration” NCT04787887 ↗ |